Literature DB >> 9486500

Complete heart block in association with graft-versus-host disease.

A L Gilman1, N W Kooy, D L Atkins, Z Ballas, S Rumelhart, M Holida, N Lee, F Goldman.   

Abstract

An infant who received haploidentical BM for severe combined immunodeficiency (SCID) developed acute, reversible complete heart block in association with an exacerbation of GVHD. Respiratory distress and myocardial dysfunction were also seen with this and previous GVHD exacerbations. The patient had not received chemotherapy or radiation prior to BMT. The complete heart block resolved after 1 week of intensive immunosuppression. The association of complete heart block with GVHD is important because the heart block is potentially reversible with prompt, aggressive control of the GVHD.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9486500     DOI： 10.1038/sj.bmt.1701038

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


  4 in total

Review 1.  Chronic graft-versus-host disease (GVHD) in children.

Authors:  Kristin Baird; Kenneth Cooke; Kirk R Schultz
Journal:  Pediatr Clin North Am       Date:  2010-02       Impact factor: 3.278

2.  Pathological features of bone marrow transplantation-related toxicity in a mouse.

Authors:  Yong Hoon Kim; Chang Su Ha; Hyun Sook Lee; Sun Hwa Lim; Kyoung Sik Moon; Moon Koo Chung; Hwa Young Son
Journal:  J Vet Sci       Date:  2009-12       Impact factor: 1.672

3.  Extracorporeal life support survival in a pediatric hematopoietic cellular transplant recipient with presumed GvHD-related fulminant myocarditis.

Authors:  M S Zinter; B D Barrows; P C Ursell; K Kowalek; K Kalantar; N Cambronero; J L DeRisi; P Oishi; C C Dvorak
Journal:  Bone Marrow Transplant       Date:  2017-06-05       Impact factor: 5.483

Review 4.  Myocarditis with Advanced Atrioventricular Block after Allogeneic Stem Cell Transplantation: A Case Report and Literature Review.

Authors:  Masahiko Sumi; Mari Kitahara; Tsutomu Shishido; Hiroko Kazumoto; Nozomu Uematsu; Takehiko Kirihara; Keijiro Sato; Toshimitsu Ueki; Yuki Hiroshima; Kunihiko Shimizu; Hikaru Kobayashi
Journal:  Intern Med       Date:  2019-08-28       Impact factor: 1.271
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.